Lion Point Capital, LP Lumos Pharma, Inc. Transaction History
Lion Point Capital, LP
- $37.2 Million
- Q3 2024
A detailed history of Lion Point Capital, LP transactions in Lumos Pharma, Inc. stock. As of the latest transaction made, Lion Point Capital, LP holds 39,589 shares of LUMO stock, worth $171,420. This represents 0.41% of its overall portfolio holdings.
Number of Shares
39,589
Previous 90,794
56.4%
Holding current value
$171,420
Previous $210,000
27.14%
% of portfolio
0.41%
Previous 0.45%
Shares
5 transactions
Others Institutions Holding LUMO
# of Institutions
33Shares Held
2.2MCall Options Held
0Put Options Held
0-
Private Advisor Group, LLC745KShares$3.22 Million0.02% of portfolio
-
Goldman Sachs Group Inc New York, NY362KShares$1.57 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA244KShares$1.06 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny214KShares$925,8140.0% of portfolio
-
Jefferies Financial Group Inc. New York, NY121KShares$522,4180.0% of portfolio
About LUMOS PHARMA, INC.
- Ticker LUMO
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 8,396,070
- Market Cap $36.4M
- Description
- Lumos Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of therapeutics for rare diseases. Its lead therapeutic candidate LUM-201 is an oral growth hormone secretagogue ibutamoren, which is in Phase 2 clinical trial for the treatment of pediatric growth hormone deficiency and other rare en...